These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21075579)

  • 1. Life-threatening hyperkalemia from nutritional supplements: uncommon or undiagnosed?
    John SK; Rangan Y; Block CA; Koff MD
    Am J Emerg Med; 2011 Nov; 29(9):1237.e1-2. PubMed ID: 21075579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and management of poisoning due to potassium chloride.
    Saxena K
    Med Toxicol Adverse Drug Exp; 1989; 4(6):429-43. PubMed ID: 2689836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I; Yalcin S; Ozhan H
    Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperkalemia.
    Hollander-Rodriguez JC; Calvert JF
    Am Fam Physician; 2006 Jan; 73(2):283-90. PubMed ID: 16445274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.
    Freeman K; Feldman JA; Mitchell P; Donovan J; Dyer KS; Eliseo L; White LF; Temin ES
    Acad Emerg Med; 2008 Mar; 15(3):239-49. PubMed ID: 18304054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced hyperkalemia: old culprits and new offenders.
    Perazella MA
    Am J Med; 2000 Sep; 109(4):307-14. PubMed ID: 10996582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG; Mioduch HJ
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management.
    McCullough PA; Beaver TM; Bennett-Guerrero E; Emmett M; Fonarow GC; Goyal A; Herzog CA; Kosiborod M; Palmer BF
    Rev Cardiovasc Med; 2014; 15(1):11-23. PubMed ID: 24762462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approach to hyperkalemia.
    Kim HJ; Han SW
    Nephron; 2002; 92 Suppl 1():33-40. PubMed ID: 12401936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic manifestations of hyperkalemia.
    Mattu A; Brady WJ; Robinson DA
    Am J Emerg Med; 2000 Oct; 18(6):721-9. PubMed ID: 11043630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals.
    Noize P; Bagheri H; Durrieu G; Haramburu F; Moore N; Giraud P; Galinier M; Pourrat J; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):747-53. PubMed ID: 21438068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of extreme hyperkalemia caused by diabetic ketoacidosis, potassium-sparing diuretics and potassium substitutes].
    Nikolić-Djurović M; Marisavljević D; Popović-Brkić V; Mićić J
    Srp Arh Celok Lek; 1990; 118(9-10):407-10. PubMed ID: 2129365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening hyperkalemia: a potentially lethal drug combination.
    Juvet T; Gourineni VC; Ravi S; Zarich SW
    Conn Med; 2013 Sep; 77(8):491-3. PubMed ID: 24156179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-fatal hyperkalemia due to ingestion of salt substitute by an infant.
    Kallen RJ; Rieger CH; Cohen HS; Sutter MA; Ong RT
    JAMA; 1976 May; 235(19):2125-6. PubMed ID: 946541
    [No Abstract]   [Full Text] [Related]  

  • 19. Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs.
    Berkova M; Berka Z; Topinkova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):84-91. PubMed ID: 23128820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies.
    Pepin J; Shields C
    Emerg Med Pract; 2012 Feb; 14(2):1-17; quiz 17-8. PubMed ID: 22413702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.